Colin Brooks
Overview
Explore the profile of Colin Brooks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ewing J, Oommen T, Thomas J, Kasaragod A, Dobson R, Brooks C, et al.
Sensors (Basel)
. 2023 Jul;
23(12).
PMID: 37420672
Terrain traversability is critical for developing Go/No-Go maps for ground vehicles, which significantly impact a mission's success. To predict the mobility of terrain, one must understand the soil characteristics. In-situ...
2.
Scarpa G, Starrett J, Li G, Brooks C, Morohashi Y, Yazaki-Sugiyama Y, et al.
Cereb Cortex
. 2022 Jul;
33(7):3401-3420.
PMID: 35849820
Sensory neurons parse millisecond-variant sound streams like birdsong and speech with exquisite precision. The auditory pallial cortex of vocal learners like humans and songbirds contains an unconventional neuromodulatory system: neuronal...
3.
Schuster S, Scharinger M, Brooks C, Lahiri A, Hartwigsen G
Hum Brain Mapp
. 2018 Mar;
39(6):2317-2328.
PMID: 29498763
Morphological complexity is a highly debated issue in visual word recognition. Previous neuroimaging studies have shown that speakers are sensitive to degrees of morphological complexity. Two-step derived complex words (bridging...
4.
Brooks C, Sheu T, Bridges K, Mason K, Kuban D, Mathew P, et al.
Radiat Oncol
. 2012 Sep;
7:154.
PMID: 22967802
Background: Many prostate cancers demonstrate an increased expression of growth factor receptors such as vascular endothelial growth factor receptor (VEGFR) and platelet derived growth factor receptor (PDGFR) which have been...
5.
Bridges K, Hirai H, Buser C, Brooks C, Liu H, Buchholz T, et al.
Clin Cancer Res
. 2011 Jul;
17(17):5638-48.
PMID: 21799033
Purpose: Radiotherapy is commonly used to treat a variety of solid tumors. However, improvements in the therapeutic ratio for several disease sites are sorely needed, leading us to assess molecularly...
6.
Fortenbery N, Paraiso K, Taniguchi M, Brooks C, Ibrahim L, Kerr W
J Immunol
. 2010 Apr;
184(9):5065-74.
PMID: 20363967
Previously, we showed that 2B4 is a dominant inhibitory receptor in SHIP-deficient NK cells that prevents efficient cytolysis of complex targets. We show in this study that 2B4 deficiency restores...
7.
Cooper S, Day R, Brooks C, Livings C, Thomson C, Trudgill N
Cancer Causes Control
. 2009 Jun;
20(8):1459-67.
PMID: 19533393
The incidence of esophageal cancer (EC), particularly esophageal adenocarcinoma (EAC), has been rising dramatically. In the USA, esophageal squamous cell carcinoma (ESCC) is associated with deprivation and black ethnicity, while...
8.
Tanaka T, Munshi A, Brooks C, Liu J, Hobbs M, Meyn R
Clin Cancer Res
. 2008 Feb;
14(4):1266-73.
PMID: 18281562
Purpose: Overexpression of the epidermal growth factor receptor (EGFR) promotes unregulated growth, inhibits apoptosis, and likely contributes to clinical radiation resistance of non-small cell lung cancer (NSCLC). Molecular blockade of...